Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44,542,200
-
Total 13F shares
-
9,735,757
-
Share change
-
+3,000,402
-
Total reported value
-
$126,197,000
-
Price per share
-
$12.96
-
Number of holders
-
49
-
Value change
-
+$40,257,091
-
Number of buys
-
43
-
Number of sells
-
8
Institutional Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) as of Q2 2020
As of 30 Jun 2020,
TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,735,757 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Essex Woodlands Management, Inc., RTW INVESTMENTS, LP, Alyeska Investment Group, L.P., COWEN AND COMPANY, LLC, SILVERCREST ASSET MANAGEMENT GROUP LLC, Pentwater Capital Management LP, BlackRock Inc., SANDERS MORRIS HARRIS LLC, and Opaleye Management Inc..
This page lists
49
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.